Takeda Abbott Pharmaceuticals Sues Atrix
Takeda Abbott Pharmaceuticals Products, Takeda Chemical Industries and Wako Pure Chemical Industries sued Atrix Laboratories and its licensee, Sanofi-Synthelabo, alleging that Atrix's Eligard delivery system infringes on a patent for a...To view the full article, register now.
Already a subscriber? Click here to view full article